SAT-13

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSAT-13
Drug Alias NameRAD51-BRCA2 protein-protein interaction inhibitors (Satya Pharma Innovations)SAT-401-0013SAT-13
ClassificationSmall molecules
Mechanisms of ActionDNA repair protein RAD51 homolog 1 inhibitorsBreast cancer type 1 susceptibility protein inhibitors
TargetsBreast cancer type 1 susceptibility proteinDNA repair protein RAD51 homolog 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSatyarx Pharma Innovations Pvt Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A